Translational optical and electrochemical biosensing strategies for liquid biopsy in triple-negative breast Cancer: advances, challenges, and clinical implementation.
Triple-negative breast cancer (TNBC) is a highly aggressive subtype with no specific therapeutic targets and a high risk of early metastases. Finally, this review emphasizes future integration of biosensors with CTC-derived organoids, microfluidics, AI, and multiplexed detection to enable portable, clinically deployable systems.
Triple-negative breast cancer (TNBC) is a highly aggressive subtype with no specific therapeutic targets and a high risk of early metastases. Finally, this review emphasizes future integration of biosensors with CTC-derived organoids, microfluidics, AI, and multiplexed detection to enable portable, clinically deployable systems.
What the study was
- Study design
- Review
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Clin Chim Acta
Why it surfaced
Matched watchlist topic(s): Early cancer detection (liquid biopsy, ctDNA, cfDNA). Study design: Review. Score 8/10. 🔴 Early cancer detection or prevention.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.